Posts

Showing posts with the label Therapeutics Area

Global Systemic Fungal Infection Therapeutics Industry : Status, Size, Share, Trends and Application 2017

Researchmoz added Most up-to-date research on "Systemic Fungal Infection Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its huge collection of research reports. Fungi inclusive of molds, mildew and yeast are types of parasites which infect various parts of the body such as the digestive tract, skin, genitals, lungs, liver and other body tissues. Systemic fungal infections are the ones in which fungi enter the bloodstream and cause more serious conditions. It is caused either by invasive organisms common in a specific geographic area or an opportunistic organism that attacks immune-suppressed individuals. These infections cause more serious effects in the immune-compromised individuals. The different types of commonly occurring systemic fungal infections include Candidiasis, Aspergillosis, Blastomycosis, Coccidioidomycosis and Histoplasmosis. The possibility of systemic fungal infections is high in the case of oncolo...

Research of Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth

ResearchMoz presents this most up-to-date research on Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth. GBI Research, a leading business intelligence provider, has released its latest research report “ Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth.” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some classifications, melanoma of the soft parts (non-bony and non-cartilaginous tissues) of the body. CM is by far the most common form of melanoma, accounting for approximately 90–95% of all melanomas. Historically, melanoma has been considered as a very challenging disease to treat with pharmacotherapy. However, in recent years, understanding of the pathophysiology and heterogeneity of melanoma, and particularly CM, has developed con...